1 Followers on Owler
OST is an-England based clinical stage biopharmaceutical company that research and develops products for the treatment of osteosarcoma and other solid tumors... Read more
OverviewFundingNews & Insights
OST is an-England based clinical stage biopharmaceutical company that research and develops products for the treatment of osteosarcoma and other solid tumors... Read more
OS Therapies President & CEO: Paul Romness

President & CEO

Paul Romness

CEO Approval Rating

- -/100

2018

PublicIndependent CompanyNYSEOSTX

Pharmaceuticals & Biotechnology
Pharmaceuticals

Annual Revenue
<$1M
Employees
5
Funding
$20.2M

News

Conference Presentation
Mar 21, 2025
Yahoo
OS Therapies to Attend The Jones Healthcare and Technology Innovation Conference
Funding
Dec 31, 2024
Business Wire
OS Therapies received $6M in Private Placement Funding
Partnership
Dec 26, 2024
EIN Presswire
OS Therapies Partners with B2i Digital to Engage with Biotech Investors Online

Trending Companies